Challenges in the development of glaucoma neuroprotection therapy

Cell and Tissue Research

Volumn 353, Issue 2, 2013, Pages 253-260

  Liu, Yang ^a   Pang, Iok Hou ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Glaucoma; Neuroprotection; Optic neuropathy; Retinopathy; Therapy

Indexed keywords

BRIMONIDINE; CILIARY NEUROTROPHIC FACTOR; ELIPRODIL; GANGLIOSIDE GM1; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; TIMOLOL;

EXCITOTOXICITY; GLAUCOMA; GLIOSIS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; PATHOGENESIS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA INJURY; RETINOPATHY; REVIEW; VISUAL FIELD DEFECT;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG DISCOVERY; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84880828122     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1584-z     Document Type: Review

References (77)

1. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A (2012) The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 31:152-181
2. Artes PH, Chauhan BC (2005) Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res 24:333-354
3. Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC (2005) Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci 46:4600-4606
4. Azuma N, Kawamura M, Kohsaka S (1989) Morphological and immunohistochemical studies on degenerative changes of the retina and the optic nerve in neonatal rats injected with monosodium-L-glutamate. Nippon Ganka Gakkai Zasshi 93:72-79
5. Bowd C, Zangwill LM, Medeiros FA, Tavares IM, Hoffmann EM, Bourne RR, Sample PA, Weinreb RN (2006) Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry. Invest Ophthalmol Vis Sci 47:2889-2895
6. Broman AT, Quigley HA, West SK, Katz J, Munoz B, Bandeen-Roche K, Tielsch JM, Friedman DS, Crowston J, Taylor HR, Varma R, Leske MC, Bengtsson B, Heijl A, He M, Foster PJ (2008) Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49:66-76
7. Caprioli J, Zeyen T (2009) A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy. J Glaucoma 18:S1-S21
8. Carter-Dawson L, Crawford ML, Harwerth RS, Smith EL 3rd, Feldman R, Shen FF, Mitchell CK, Whitetree A (2002) Vitreal glutamate concentration in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci 43:2633-2637
9. Chauhan BC, Garway-Heath DF, Goni FJ, Rossetti L, Bengtsson B, Viswanathan AC, Heijl A (2008) Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 92:569-573
10. Chen YJ, Tai MC, Cheng JH, Chen JT, Chen YH, Lu DW (2012) The longitudinal changes of the visual field in an Asian population with primary angle-closure glaucoma with and without an acute attack. J Ocul Pharmacol Ther 28:529-535
11. Clark AF, Yorio T (2003) Ophthalmic drug discovery. Nat Rev Drug Discov 2:448-459
12. de Araujo EG, Linden R (1993) Trophic factors produced by retinal cells increase the survival of retinal ganglion cells in vitro. Eur J Neurosci 5:1181-1188
13. Deng J, Wu DZ, Gao R (2000) Detection of glutamate and gamma-aminobutyric acid in vitreous of patients with proliferative diabetic retinopathy. Yan ke xue bao 16:199-202
14. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299-305
15. Ferrari G, Greene LA (1998) Promotion of neuronal survival by GM1 ganglioside. Phenomenology and mechanism of action. Ann N Y Acad Sci 845:263-273
16. Furuya T, Pan Z, Kashiwagi K (2012) Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptor. Curr Eye Res 37:170-178
17. Gao H, Qiao X, Cantor LB, WuDunn D (2002) Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 120:797-803
18. Hare WA, Wheeler L (2009) Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine. Invest Ophthalmol Vis Sci 50:2940-2948
19. Hare WA, WoldeMussie E, Weinreb RN, Ton H, Ruiz G, Wijono M, Feldmann B, Zangwill L, Wheeler L (2004) Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey. II. Structural measures. Invest Ophthalmol Vis Sci 45:2640-2651
20. Harris A, Sergott RC, Spaeth GL, Katz JL, Shoemaker JA, Martin BJ (1994) Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol 118:642-649
21. Heijl A, Bengtsson B, Hyman L, Leske MC (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271-2276
22. Hellstrom M, Pollett MA, Harvey AR (2011) Post-injury delivery of rAAV2-CNTF combined with short-term pharmacotherapy is neuroprotective and promotes extensive axonal regeneration after optic nerve trauma. J Neurotrauma 28:2475-2483
23. Hwang JC, Konduru R, Zhang X, Tan O, Francis BA, Varma R, Sehi M, Greenfield DS, Sadda SR, Huang D (2012) Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci 53:3020-3026
24. Jia Y, Morrison JC, Tokayer J, Tan O, Lombardi L, Baumann B, Lu CD, Choi W, Fujimoto JG, Huang D (2012) Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express 3:3127-3137
25. Johnson TV, Tomarev SI (2010) Rodent models of glaucoma. Brain Res Bull 81:349-358
26. Ju WK, Kim KY (2011) Measuring glutamate receptor activation-induced apoptotic cell death in ischemic rat retina using the TUNEL assay. Methods Mol Biol 740:149-156
27. Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN (2009) Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 50:707-716
28. Kaiser HJ, Flammer J, Burckhardt D (1993) Silent myocardial ischemia in glaucoma patients. Ophthalmologica 207:6-7
29. Kapin MA, Doshi R, Scatton B, DeSantis LM, Chandler ML (1999) Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Invest Ophthalmol Vis Sci 40:1177-1182
30. Kim JM, Sae Kim M, Ju Jang H, Ho Park K, Caprioli J (2012) The association between retinal vessel diameter and retinal nerve fiber layer thickness in asymmetric normal tension glaucoma patients. Invest Ophthalmol Vis Sci 53:5609-5614
31. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S (2011) A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 151:671-681
32. Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39:1063-1066
33. Lam TT, Kwong JM, Tso MO (2003) Early glial responses after acute elevated intraocular pressure in rats. Invest Ophthalmol Vis Sci 44:638-645
34. Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V, Manni GL, Bucci MG, Bonini S, Levi-Montalcini R (2009) Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci USA 106:13469-13474
35. Leung CK, Cheung CY, Weinreb RN, Qiu Q, Liu S, Li H, Xu G, Fan N, Huang L, Pang CP, Lam DS (2009) Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology 116:1257-1263
36. Levinger E, Zemel E, Perlman I (2012) The effects of excitatory amino acids and their transporters on function and structure of the distal retina in albino rabbits. Doc Ophthalmol 125:249-265
37. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622
38. Liu B, Neufeld AH (2001) Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch Ophthalmol 119:240-245
39. Lucas DR, Newhouse JP (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58:193-201
40. Luo X, Heidinger V, Picaud S, Lambrou G, Dreyfus H, Sahel J, Hicks D (2001) Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci 42:1096-1106
41. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321:519-522
42. Minckler DS, Bunt AH, Johanson GW (1977) Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 16:426-441
43. Muller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D (2009) Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol Cell Neurosci 41:233-246
44. Murphy JA, Clarke DB (2006) Target-derived neurotrophins may influence the survival of adult retinal ganglion cells when local neurotrophic support is disrupted: implications for glaucoma. Med Hypotheses 67:1208-1212
45. Naskar R, Vorwerk CK, Dreyer EB (2000) Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci 41:1940-1944
46. Neufeld AH, Sawada A, Becker B (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96:9944-9948
47. Osborne NN (2009) Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol 87:450-454
48. Pang IH, Clark AF (2007) Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma 16:483-505
49. Pang IH, Wexler EM, Nawy S, DeSantis L, Kapin MA (1999) Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells. Invest Ophthalmol Vis Sci 40:1170-1176
50. Pang IH, Johnson EC, Jia L, Cepurna WO, Shepard AR, Hellberg MR, Clark AF, Morrison JC (2005a) Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage. Invest Ophthalmol Vis Sci 46:1313-1321
51. Pang IH, Wang WH, Clark AF (2005b) Acute effects of glaucoma medications on rat intraocular pressure. Exp Eye Res 80:207-214
52. Park CK, Cha J, Park SC, Lee PY, Kim JH, Kim HS, Kim SA, Kim IB, Chun MH (2009) Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma. Exp Brain Res 197:101-109
53. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41:764-774
54. Prasanna G, Krishnamoorthy R, Yorio T (2011) Endothelin, astrocytes and glaucoma. Exp Eye Res 93:170-177
55. Quigley HA (2012) Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol 23:144-154
56. Quigley H, Anderson DR (1976) The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol 15:606-616
57. Quigley HA, Addicks EM, Green WR, Maumenee AE (1981) Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 99:635-649
58. Quigley HA, Addicks EM, Green WR (1982) Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 100:135-146
59. Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, Kerrigan DF, Mitchell RS (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 41:3460-3466
60. Rader J, Feuer WJ, Anderson DR (1994) Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthal 117:72-80
61. Raschetti R, Maggini M, Popoli P, Caffari B, Da Cas R, Menniti-Ippolito F, Spila-Alegiani S, Traversa G (1995) Gangliosides and Guillain-Barre syndrome. J Clin Epidemiol 48:1399-1405
62. Rehen SK, Ary-Pires R, Linden R (1993) Intraretinal neurotrophic activity prevents the degeneration of ganglion cells in retinal explants. Braz J Med Biol Res 26:955-959
63. Saylor M, McLoon LK, Harrison AR, Lee MS (2009) Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 127:402-406
64. Schwid SR, Cutter GR (2006) Futility studies: spending a little to save a lot. Neurology 66:626-627
65. Sehi M, Grewal DS, Sheets CW, Greenfield DS (2009) Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol 148:597-605
66. Smith SD, Katz J, Quigley HA (1996) Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37:1419-1428
67. Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, Quigley HA, Marsh-Armstrong N (2010) Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58:780-789
68. Stasi K, Nagel D, Yang X, Wang RF, Ren L, Podos SM, Mittag T, Danias J (2006) Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci 47:1024-1029
69. Sucher NJ, Lei SZ, Lipton SA (1991) Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res 551:297-302
70. Waldmann E, Gasser P, Dubler B, Huber C, Flammer J (1996) Silent myocardial ischemia in glaucoma and cataract patients. Graefes Arch Clin Exp Ophthalmol 234:595-598
71. Wang L, Cioffi GA, Cull G, Dong J, Fortune B (2002) Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci 43:1088-1094
72. Wax M, Yang J, Tezel G (2002) Autoantibodies in glaucoma. Curr Eye Res 25:113-116
73. Weinreb RN, Kaufman PL (2011) Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci 52:7842-7851
74. Wen R, Cheng T, Li Y, Cao W, Steinberg RH (1996) Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 16:5986-5992
75. Yang J, Patil RV, Yu H, Gordon M, Wax MB (2001) T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol 131:421-426
76. Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64:523-532
77. Zhu H, Crabb DP, Schlottmann PG, Lemij HG, Reus NJ, Healey PR, Mitchell P, Ho T, Garway-Heath DF (2010) Predicting visual function from the measurements of retinal nerve fiber layer structure. Invest Ophthalmol Vis Sci 51:5657-5666